METTL3 and acute myeloid leukemia: Vu et al., 2017 have demonstrated the role of m6A writer enzyme ‘Mettl3’ in AML progression [43] supported by Barbieri et al., 2017 [44] and enlightened the molecular mechanism to control leukaemia.